Clinical Guidance for RSV Immunizations and Vaccines
Click on the pages below to learn more about RSV vaccine and immunizations for each population: Immunization guidance for healthcare providers for the use of nirsevimab. Vaccine guidance for healthcare providers for the use of the RSV maternal vaccine (Pfizer's Abrysvo).
RSV Vaccine Guidance for Older Adults | RSV | CDC - Centers for …
Aug 30, 2024 · CDC recommends a single dose of RSV vaccine for older adults to help prevent serious RSV infection and hospitalization. RSV vaccination is recommended for the following adults: All adults ages 75 and older. Adults ages 60–74 at increased risk of severe RSV disease.
RSV is an RNA virus, and transmission occurs primarily via respiratory droplets when a person coughs or sneezes, or through direct contact with a contaminated surface. Infants, young children, and older adults, especially those with chronic medical conditions, are at increased risk of severe disease from RSV infection.
Surveillance of RSV | RSV | CDC - Centers for Disease Control and ...
Aug 30, 2024 · CDC has several systems that focus on monitoring and describing seasonal trends, clinical risk factors, rates of illness and hospitalization, and demographics of patients seeking care for illness associated with respiratory syncytial virus (RSV).
CDC Updates RSV Vaccination Recommendation for Adults
Jun 26, 2024 · Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: Everyone ages 75 and older receive the RSV vaccine.
RSV-NET | RSV | CDC - Centers for Disease Control and Prevention
Oct 10, 2024 · The Respiratory Syncytial Virus (RSV) Hospitalization Surveillance Network (RSV-NET) monitors laboratory-confirmed, RSV-associated hospitalizations among children and adults.
RSV Immunization Guidance for Infants and Young Children
What to know. To prevent severe RSV disease in infants, either maternal RSV vaccination or infant immunization with the RSV monoclonal antibody (nirsevimab) is recommended. Most infants will not need both. Administration of nirsevimab is recommended during October through March in most of the U.S.
RSV in Infants and Young Children | RSV | CDC - Centers for …
Aug 30, 2024 · RSV can be dangerous for infants and some young children. RSV is the leading cause of infant hospitalization in the U.S. Immunizations can protect babies from getting very sick from RSV.
2024-2025 Respiratory Disease Season Outlook – October Update
CDC continues to expect the fall and winter respiratory disease season will likely have a similar or lower number of combined peak hospitalizations due to COVID-19, influenza, and RSV compared to last season. Vaccination is expected to play a key role in preventing hospitalizations.
Disease Severity of Respiratory Syncytial Virus ...
Oct 5, 2023 · In June 2023, CDC recommended the first respiratory syncytial virus (RSV) vaccines for adults aged ≥60 years using shared clinical decision-making. Understanding the severity of RSV disease is needed to guide this clinical decision-making.